APA

Gelsomino F., Fiorentino M., Zompatori M., Poerio A., Melotti B., Sperandi F., Gargiulo M., Borghi C. & Ardizzoni A. (20190403). Programmed death-1 inhibition and atherosclerosis: can nivolumab vanish complicated atheromatous plaques?. : Annals of oncology : official journal of the European Society for Medical Oncology.

Chicago

Gelsomino F, Fiorentino M, Zompatori M, Poerio A, Melotti B, Sperandi F, Gargiulo M, Borghi C and Ardizzoni A. 20190403. Programmed death-1 inhibition and atherosclerosis: can nivolumab vanish complicated atheromatous plaques?. : Annals of oncology : official journal of the European Society for Medical Oncology.

Harvard

Gelsomino F., Fiorentino M., Zompatori M., Poerio A., Melotti B., Sperandi F., Gargiulo M., Borghi C. and Ardizzoni A. (20190403). Programmed death-1 inhibition and atherosclerosis: can nivolumab vanish complicated atheromatous plaques?. : Annals of oncology : official journal of the European Society for Medical Oncology.

MLA

Gelsomino F, Fiorentino M, Zompatori M, Poerio A, Melotti B, Sperandi F, Gargiulo M, Borghi C and Ardizzoni A. Programmed death-1 inhibition and atherosclerosis: can nivolumab vanish complicated atheromatous plaques?. : Annals of oncology : official journal of the European Society for Medical Oncology. 20190403.